Records 1 - 4
| Relationship Between Single-Nucleotide Polymorphisms of Tumor Necrosis Factor Alpha, Interleukin-10, Factor II and Factor V with Risk of Inhibitor Development in Patients with Severe Hemophilia A.
Cardiovascular & hematological disorders drug targets 2019 Feb .
Souri Shahrzad, Dadashizadeh Ghazaleh, Dorgalaleh Akbar, Tabibian Shadi, Keramati Mohammad Reza, Alizadeh Shaban, Hosseini Maryam Sadat, Zaker Farhad, Shams Mahmo
| The Development of FVIII Inhibitors in Relation to IL10 Gene Polymorphism in Hemophilia A Egyptian Pediatric Patients.
Fetal and pediatric pathology 2017 Jun 36 (3): 184-189.
Sadek Hoda, Youssry Ilham, Ibrahim Nihal Salah Eldeen, Abou-Elalla Amany Ahmed, Atef Gehad, Mousa Somaia Mohamm
| Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival.
Journal of acquired immune deficiency syndromes (1999) 2008 Jul 48 (3): 263-71.
Hendrickson Sher L, Jacobson Lisa P, Nelson George W, Phair John P, Lautenberger James, Johnson Randall C, Kingsley Lawrence, Margolick Joseph B, Detels Roger, Goedert James J, O'Brien Stephen
| Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A.
Blood 2006 Apr 107 (8): 3167-72.
Astermark Jan, Oldenburg Johannes, Pavlova Anna, Berntorp Erik, Lefvert Ann-Kari,